U.S. Banks Stock News

Old Republic International (NYSE:ORI) has completed a substantial fixed-income offering, issuing new callable, senior, unsecured notes. The transaction adds fresh debt capital to the balance sheet, with terms structured around future call dates and interest payments. This funding move is designed to influence the company’s financial flexibility and long term funding mix. For investors tracking NYSE:ORI, the deal comes with the stock at $39.32 and a mixed return profile. Shares are up 11.4%...

Brighthouse Financial, Inc. has reported first-quarter 2026 results, with revenue of US$1,527 million versus US$2,390 million a year earlier and a net loss of US$766 million, including a diluted loss per share from continuing operations of US$13.82, all reflecting a marked deterioration from the prior year period. These weaker results, marked by a very large year-over-year increase in net loss, raise fresh questions about the resilience of Brighthouse Financial’s earnings profile and...

Cerebras Systems (NasdaqGS: CBRS) completed the largest U.S. tech IPO since 2020, listing on the Nasdaq with strong institutional demand. The company is partnering with OpenAI and Amazon Web Services to supply AI infrastructure built around its custom semiconductor technology. The IPO is being viewed as a key moment for the AI chip sector, highlighting investor interest in alternatives to established AI hardware providers. Cerebras Systems now trades on the Nasdaq under the ticker NasdaqGS:...

Danaos (NYSE:DAC) reports limited earnings impact from recent geopolitical disruptions, including the closure of the Strait of Hormuz, supported by long term charter coverage. The company is expanding its fleet in drybulk and LNG, adding Newcastlemax dry bulk carriers and 5,000 TEU containerships under new vessel orders. Contracted revenue backlog and additional energy sector investments point to a broader shift in how Danaos positions its shipping operations. For investors tracking...

Wondering if DexCom at around US$61.63 is starting to look interesting again, or if the stock still carries too much downside risk for your portfolio? The share price has inched up about 1.7% over the past week and 0.7% over the past month, but is still down about 7.4% year to date and has declined about 27.9% over the past year. Recent headlines have focused on DexCom's role in continuous glucose monitoring and how that fits into broader healthcare technology trends, which can shape how...

Hut 8 (NasdaqGS:HUT) has engaged Jacobs to provide engineering, procurement, and construction management services for its Beacon Point AI data center in Texas. The partnership moves the Beacon Point project from contract stage into execution, with plans that include digital twin technology and potential capacity up to 1 GW. The Jacobs EPCM deal marks a shift for Hut 8 from signing large Beacon Point and River Bend contracts to starting physical buildout at Beacon Point. The stock trades at...

Calix expanded its AI-native Calix One platform to support standards-based 50G-PON. The company introduced an expanded Wi-Fi 7 appliance portfolio for service providers. The updates are aimed at residential, business, and multi-dwelling unit connectivity needs and federally funded broadband projects. Calix (NYSE:CALX) is pushing deeper into next generation fiber and wireless broadband with the 50G-PON extension to Calix One and a broader set of Wi-Fi 7 systems. The stock trades at $39.81,...

Zenas BioPharma (ZBIO) has just cleared a major clinical hurdle, reporting that lead antibody obexelimab met primary and key secondary endpoints in a Phase 3 IgG4-related disease trial while also starting first-in-human dosing for oral IL-17 inhibitor ZB021. See our latest analysis for Zenas BioPharma. Despite the positive obexelimab Phase 3 result and progress with ZB021, momentum in the share price has cooled recently, with the stock down 30.53% on a 90 day share price return and 46.84%...

Globus Medical (GMED) has fallen about 17% over the past week, even as its recent quarterly report showed higher sales and earnings and reaffirmed full year revenue guidance, putting the stock under closer investor scrutiny. See our latest analysis for Globus Medical. The recent 30 day share price return is down 18.94%, adding to a weaker 90 day share price return of 13% and pointing to fading short term momentum, even as the 1 year total shareholder return is 25.13%. If this kind of...

Recent price moves and what they might signal Cal-Maine Foods (CALM) has seen mixed share performance recently, with the stock down over the past year but higher over the past month, prompting investors to reassess how current pricing lines up with fundamentals. See our latest analysis for Cal-Maine Foods. At a share price of $76.88, Cal-Maine Foods has seen short-term share price returns edge higher in recent weeks while the 1-year total shareholder return is still down, although the 3-year...

Zevra Therapeutics reported first-quarter 2026 results showing sales of US$36.22 million and net income of US$37.89 million, a shift from a net loss a year earlier. The strong profit print was partly driven by unusual items and comes amid recent shareholder dilution, prompting closer scrutiny of the earnings quality. We’ll now explore how the earnings jump, aided by unusual items, affects Zevra Therapeutics’ existing investment narrative in rare disease therapies. We've uncovered the 12...

Dauch Corporation recently reported past first-quarter 2026 results, with sales rising to US$2,378.9 million from US$1,411.3 million a year earlier, alongside a net loss of US$100.3 million and a basic loss per share of US$0.52 from continuing operations. The company also modestly raised its 2026 sales guidance to a range of US$10.30–US$10.80 billion while still projecting a sizeable full-year net loss between US$335 million and US$180 million, highlighting a tension between revenue growth...

If you are wondering whether McDonald's at around US$276 per share still justifies a place in your portfolio, the key question is what you are really paying for today. The stock has been fairly flat over the last week with a 0.2% gain, but is down 9.8% over the past month and down 11.2% over the last year, which can change how the market views its potential and risk. Recent coverage has focused on how McDonald's is handling changing consumer habits and competitive pressure in quick service...

Newmont (NYSE:NEM) is exploring a potential partnership with Barrick on the Fourmile gold discovery, often described as one of the century’s largest finds. The two companies are reported to be in early discussions on a development agreement that could shape the long term future of the Fourmile asset. Separately, Newmont has increased its ownership stake in Solitario Resources Corp., expanding its exposure to additional mining assets. Newmont, trading at $109.06, has a mixed recent track...

Earlier in May 2026, Grindr reported first-quarter 2026 results showing revenue of US$129.94 million and net income of US$26.75 million, raised its full-year 2026 revenue guidance to at least US$535 million, and brought back its Host or Travel original series to showcase LGBTQ+ travel and in-app engagement trends across major global cities. By pairing stronger guidance with content like Host or Travel that highlights real-world usage patterns and cross-border connections, Grindr is...

Recent performance context for Centrus Energy (LEU) Centrus Energy (LEU) has attracted fresh attention after its recent share performance, with the stock down 5.1% on the day and lower over the past week, month, and past 3 months. See our latest analysis for Centrus Energy. The recent pullback, with the share price down 33% year to date to US$182.60 and weaker short term share price returns, contrasts with a very strong 1 year total shareholder return of 90.7% and an even larger 5 year total...

In early May 2026, The RealReal reported first-quarter results showing year-over-year growth in sales to US$25.81 million and revenue to US$189.72 million, alongside positive net income of US$38.94 million, and also filed a universal shelf registration covering multiple security types. The company’s decision to raise full-year 2026 revenue guidance to US$770 million–US$784 million, while simultaneously putting a broad shelf registration in place, highlights management’s confidence in the...

CenterPoint Energy (NYSE:CNP) launched a new at the market equity distribution program for up to US$1b in common stock, replacing a prior arrangement. The company filed a new shelf registration statement covering a range of potential debt and equity securities. CenterPoint outlined ongoing investments in storm resilience, including a large hurricane response exercise and its Greater Houston Resiliency Initiative. CenterPoint Energy, a regulated utility serving electric and natural gas...

Rayonier shareholders approved all director nominees at the 2026 Annual Meeting. Investors also backed the company’s executive compensation program. The meeting included ratification of Rayonier’s independent auditor. For investors tracking Rayonier (NYSE:RYN), the 2026 Annual Meeting outcomes indicate continued alignment between shareholders and the board. All director nominees, executive pay packages, and the auditor ratification received approval, reinforcing the current governance...

Hawkins, Inc. reported past full-year 2026 results with sales rising to US$1,083.7 million while net income and diluted EPS eased slightly, and its board declared a quarterly dividend of US$0.19 per share payable in June 2026. The year’s record revenue was driven largely by strong expansion in the Water Treatment segment, boosted by six acquisitions that also increased interest and acquisition-related costs. We’ll now examine how this revenue growth led by Water Treatment, alongside the...

If you are wondering whether First Financial Bankshares at around US$31.10 still offers value, the next sections will focus squarely on what the current price implies. The stock has slipped about 3.6% over the last week, is roughly flat over the past month with a 0.5% gain, has added 3.6% year to date, but is down about 11.2% over 1 year and around 31.2% over 5 years. This provides important context before looking at any valuation metrics. Recent coverage has focused on how regional banks...

Loma Negra Compañía Industrial Argentina Sociedad Anónima recently reported first-quarter 2026 results, with sales of ARS 218,739 million and net income of ARS 41,004 million, alongside higher earnings per share from continuing operations versus a year earlier. An interesting takeaway is that management credited a rebound in March cement activity and stronger margins for offsetting earlier industry softness and improving cash flow. Next, we’ll explore how this margin improvement and...

Pershing Square stock performance snapshot Pershing Square (PS) has drawn attention after a recent pullback, with the stock down about 3.4% over the past day and slightly lower over the past week, despite a strong year-to-date gain of roughly 70%. See our latest analysis for Pershing Square. The recent pullback, with a 1 day share price return down about 3.4% to US$41.17 and a modest 7 day decline, follows a much stronger year to date share price return of roughly 70%. This suggests shorter...

West Pharmaceutical Services (NYSE:WST) reported a material cybersecurity incident involving data exfiltration and system encryption. The attack triggered a temporary suspension of global operations while the company worked to contain the breach. The full operational and financial impact remains uncertain as investigations and system restoration continue. West Pharmaceutical Services steps into this cyber event after a period of strong share price performance, with the stock up 40.3% over...